Terug
Dagbereik
€ 11,12
€ 11,63
52-Weeksbereik
€ 10,75
€ 32,76
Volume
1.549.422
50D / 200D Gem.
€ 13,24
/
€ 21,38
Vorige Slotkoers
€ 11,80
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -11,6 | 0,3 |
| P/B | 2,6 | 2,9 |
| ROE % | -22,7 | 3,7 |
| Net Margin % | -13,9 | 3,8 |
| Rev Growth 5Y % | 29,6 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 27,50
+143.8%
Low: € 22,00
High: € 33,00
Forward K/W
145,1
Forward WPA
€ 0,08
WPA Groei (sch.)
+0,0%
Omzet Sch.
480 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,16
€ 1,15 – € 1,17
|
720 M | 1 |
| FY2029 |
€ 1,00
€ 0,99 – € 1,01
|
660 M | 2 |
| FY2028 |
€ 0,79
€ 0,42 – € 1,22
|
600 M | 10 |
Belangrijkste Punten
Revenue grew 29,63% annually over 5 years — strong growth
Debt/Equity of 0,07 — conservative balance sheet
Generating 8,29M in free cash flow
PEG of 0,47 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 11,80%
Capital efficient — spends only 5,74% of revenue on capex
Groei
Revenue Growth (5Y)
29,63%
Revenue (1Y)17,83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-22,67%
ROIC-15,42%
Net Margin-13,94%
Op. Margin-13,84%
Veiligheid
Debt / Equity
0,07
Current Ratio1,78
Interest Coverage-24,75
Waardering
P/E Ratio
-11,62
P/B Ratio2,57
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,83% | Revenue Growth (3Y) | 22,25% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 29,63% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 419,81M | Net Income (TTM) | -58,53M |
| ROE | -22,67% | ROA | -15,07% |
| Gross Margin | 67,86% | Operating Margin | -13,84% |
| Net Margin | -13,94% | Free Cash Flow (TTM) | 8,29M |
| ROIC | -15,42% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 1,78 |
| Interest Coverage | -24,75 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,62 | P/B Ratio | 2,57 |
| P/S Ratio | 1,62 | PEG Ratio | 0,47 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 680,04M | Enterprise Value | 613,62M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 419,81M | 356,30M | 280,91M | 213,23M | 148,68M |
| Net Income | -58,53M | -136,89M | -176,15M | -118,16M | -27,29M |
| EPS (Diluted) | -1,02 | -2,51 | -3,36 | -2,37 | -0,69 |
| Gross Profit | 284,88M | 232,29M | 171,64M | 131,85M | 96,29M |
| Operating Income | -58,10M | -136,48M | -176,55M | -116,82M | -25,67M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 388,42M | 370,33M | 370,06M | 494,48M | 326,67M |
| Total Liabilities | 123,61M | 118,88M | 82,24M | 77,20M | 63,36M |
| Shareholders' Equity | 264,81M | 251,45M | 287,82M | 417,28M | 263,31M |
| Total Debt | 17,80M | 11,98M | 9,18M | 15,80M | 14,32M |
| Cash & Equivalents | 84,22M | 87,52M | 176,68M | 313,81M | 218,78M |
| Current Assets | 203,29M | 195,68M | 262,44M | 386,35M | 272,27M |
| Current Liabilities | 114,02M | 110,12M | 79,04M | 68,43M | 54,99M |